Sail Biomedicines

News

Johnson & Johnson has bid for a slice of the in vivo CAR-T category, signing an alliance with Sail Bio that could evolve into a $2.58bn takeover.

News

Using Claude Science, Claude agents designed high-affinity protein binders for a range of targets, outperforming human experts in some cases.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.